Hopefully, more positive news flows from Human Genome Sciences' partners such as GlaxoSmithKline and other Human Genome Sciences' partners. Human Genome Sciences' strength lies in the breadth and number of its pharmaceutical and biotechnology partnerships. So far, Human Genome Sciences' shares have rallied the past few days despite the market being so fearful. It maybe a good time to book some profits. Such Information is neither an offer to sell nor a solicitation to buy the securities of any company.
Additional information is available upon request.
Information in this publication has been obtained from sources believed to be reliable, but the accuracy, completeness and interpretation are not guaranteed. Opinions expressed are subject to change without notice. The Information is supplied on the condition that the reader or any other person receiving the Information will make his or her own determination as to its suitability for any purpose prior to any use of the Information. This report may not be reproduced, distributed or published by any recipient for any purpose without the prior express consent of the publishers. Changes in rates of currency exchange may have an adverse effect on the value, price or income of investments.